Diabetic Peripheral Neuropathy
Conditions
Brief summary
The aims of this study are to determine the prevalence of diabetic peripheral neuropathy among the diabetic patients, to determine the association between the clinical profiles of the diabetic patients (diabetes type, diabetes duration, HbA1c, body mass index, hypertension, total cholesterol) and the diabetic peripheral neuropathy DPN and the rational poly pharmacy used to control pain.
Interventions
OTHERDiabetic patients with neuropathy
Lifestyle modification will be assessed using summary of diabetes self-care activity
Sponsors
Hawler Medical University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
1. Aged 18 years or older. 2. Both sex. 3. Diagnosed with type 2 diabetes at least one year previously. 4. Took at least one prescribed medication for diabetes. 5. Diagnosed as diabetic peripheral neuropathy based on clinical
Exclusion criteria
1. History of alcohol consumption. 2. Thyroid gland disorder. 3. Any kidney disorder. 4. Any conditions that could confound assessment of pain due to diabetic peripheral neuropathy. 5. Have foot injury or open sore. 6. Pregnant females or who plan to become pregnant during the study period. 7. Any serious medical condition that might prevent completion or hinder compliance with exercise. \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Estimating Summary of diabetes self-care activity (SDSCA) | Three months | Assessing Lifestyle modification by summary of diabetes self-care activity (SDSCA) at baseline visit and after three months for both Intervention patients and usual care group Increases in the means of the items of the scale as Exercise, Blood sugar testing, Specific diet and Foot care in the intervention group. |
| Adherence to treatment according to Morisky scale | Three months | Morisky scale is used to assess medication adherence at baseline visit and after three months for both Intervention patients and usual care group. Improving the patient medication adherence behavior in the intervention group patients |
| Douleur Neuropathique 4 (DN4), Neuropathic Pain Scale (NPS), | Three months | Reduction in the percent of response of patients feeling; electric shock, tingling, and pin needle after the lifestyle modification in the intervention group. |
Countries
Iraq
Outcome results
None listed